IP Library › Granted Patent US 8,639,327
Granted Patent B2
US 8,639,327 · App. 12/848,019 · Granted Jan 28, 2014

Nerve signal differentiation in cardiac therapy

Inventors: Xiaohong Zhou (Woodbury, MN); John Edward Burnes (Coon Rapids, MN); Lilian Kornet (Maastricht, NL); Richard N. M. Cornelussen (Maastricht, NL)
Assignee: Medtronic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,639,327
App. No.
12/848,019
Granted
Jan 28, 2014
Kind
B2
Abstract

Methods of nerve signal differentiation, methods of delivering therapy using such nerve signal differentiation, and to systems and devices for performing such methods. Nerve signal differentiation may include locating two electrodes proximate nerve tissue and differentiating between efferent and afferent components of nerve signals monitored using the two electrodes.

Claims (31)

1. A method of delivering therapy, wherein the method comprises:

monitoring physiological parameters of a patient, wherein the physiological parameters comprise electrical activity of the patient's vagus nerve;

determining whether the monitored electrical activity of the patient's vagus nerve comprises efferent activity;

analyzing the monitored physiological parameters, wherein analyzing the monitored physiological parameters comprises determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time; and

initiating or adjusting non-nerve stimulating cardiac therapy if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the non-nerve stimulating cardiac therapy comprises at least one of pacing therapy, cardiac resynchronization therapy, anti-tachycardia pacing, high-energy shock pulses for cardioversion/defibrillation therapy, bradycardia pacing, and drug therapy, wherein the method further comprises determining whether the monitored electrical activity of the patient's vagus nerve comprises afferent activity, and wherein determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced comprises comparing the efferent activity to the afferent activity.

2. A method of delivering therapy, wherein the method comprises:

monitoring physiological parameters of a patient, wherein the physiological parameters comprise electrical activity of the patient's vagus nerve;

determining whether the monitored electrical activity of the patient's vagus nerve comprises efferent activity;

analyzing the monitored physiological parameters, wherein analyzing the monitored physiological parameters comprises determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time; and

initiating or adjusting non-nerve stimulating cardiac therapy if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the non-nerve stimulating cardiac therapy comprises at least one of pacing therapy, cardiac resynchronization therapy, anti-tachycardia pacing, high-energy shock pulses for cardioversion/defibrillation therapy, bradycardia pacing, and drug therapy, wherein determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced comprises comparing the average amplitude of a selected frequency range of the efferent activity to a selected value.

3. A method of delivering therapy, wherein the method comprises:

monitoring physiological parameters of a patient, wherein the physiological parameters comprise electrical activity of the patient's vagus nerve;

determining whether the monitored electrical activity of the patient's vagus nerve comprises efferent activity;

analyzing the monitored physiological parameters, wherein analyzing the monitored physiological parameters comprises determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time; and initiating or adjusting non-nerve stimulating cardiac therapy if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the non-nerve stimulating cardiac therapy comprises at least one of pacing therapy, cardiac resynchronization therapy, anti-tachycardia pacing, high-energy shock pulses for cardioversion/defibrillation therapy, bradycardia pacing, and drug therapy, wherein determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced comprises comparing the average amplitude of a selected frequency range of the presently-monitored efferent activity to the average amplitude of the selected frequency range of previously-monitored efferent activity.

4. A method of delivering therapy, wherein the method comprises:

monitoring physiological parameters of a patient, wherein the physiological parameters comprise electrical activity of the patient's vagus nerve;

determining whether the monitored electrical activity of the patient's vagus nerve comprises efferent activity;

analyzing the monitored physiological parameters, wherein analyzing the monitored physiological parameters comprises determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time; and

initiating or adjusting non-nerve stimulating cardiac therapy if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the non-nerve stimulating cardiac therapy comprises at least one of pacing therapy, cardiac resynchronization therapy, anti-tachycardia pacing, high-energy shock pulses for cardioversion/defibrillation therapy, bradycardia pacing, and drug therapy, wherein determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced comprises comparing the average power of a selected frequency range of the efferent activity to a selected value.

5. A method of delivering therapy, wherein the method comprises:

monitoring physiological parameters of a patient, wherein the physiological parameters comprise electrical activity of the patient's vagus nerve;

determining whether the monitored electrical activity of the patient's vagus nerve comprises efferent activity;

analyzing the monitored physiological parameters, wherein analyzing the monitored physiological parameters comprises determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time; and

initiating or adjusting non-nerve stimulating cardiac therapy if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the non-nerve stimulating cardiac therapy comprises at least one of pacing therapy, cardiac resynchronization therapy, anti-tachycardia pacing, high-energy shock pulses for cardioversion/defibrillation therapy, bradycardia pacing, and drug therapy, wherein determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced comprises comparing the average power of a selected frequency range of the presently-monitored efferent activity to the average power of the selected frequency range of previously-monitored efferent activity.

6. The method of any of claims 1 to 5 , wherein determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced comprises comparing the pulses per second of the efferent activity to a selected value.

7. The method of any of claims 1 to 5 , wherein determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced comprises comparing the pulses per second of presently-monitored efferent activity to the pulses per second of previously-monitored efferent activity.

8. The method of any of claims 1 to 5 , wherein the physiological parameters further comprise electrical activity of the patient's heart, and wherein the method further comprises:

providing a function relating the status of the patient's vagus nerve to the electrical activity of the patient's heart for use in therapy,

assessing a status of the patient's vagus nerve using the monitored electrical activity of the patient's heart using the function, and

initiating or adjusting cardiac therapy to the patient based on the assessed status of the patient's vagus nerve.

9. The method of any of claims 1 to 5 , wherein determining whether the monitored electrical activity of the patient's vagus nerve comprises efferent activity comprises differentiating between efferent activity and afferent activity of the monitored electrical activity based on a direction of the monitored electrical activity, wherein the direction of the monitored electrical activity is determined based on at least one of polarity, timing, and velocity of the monitored electrical activity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2010
From: ZHOU, XIAOHONG; BURNES, JOHN EDWARD; KORNET, LILIAN; CORNELUSSEN, RICHARD N.M.
To: MEDTRONIC, INC.
Reel/Frame 025242/0026 →
Continuity (2)
Provisional Application 61397702 · Apr 29, 2010
Related Publication 20120029587A1 · Feb 2, 2012